Jasmine Jones

Jasmine Jones is a Washington DC-based solo angel writing sub-$25K checks at pre-seed and seed into women’s and reproductive health and digital health. The check size is small by angel standards, which positions her as an advisor-and-signal investor rather than a meaningful capital source. The DC base is somewhat unusual for healthcare angel investing, which more commonly clusters in New York, Boston, and the Bay Area, and it suggests a network that may include policy, regulatory, and federal-health-agency relationships in addition to commercial healthcare. AI is not flagged, so the framing is on practical women’s health and digital health products rather than algorithm-led pitches. Founders most likely to fit are early femtech and women’s health companies, digital health teams with a women’s health angle, and any team that benefits from a DC-based angel with potential network value into policy and federal-health communities. Pure biotech, devices, life sciences tools, SaaS for providers without a women’s health angle, and broad consumer wellness are weaker matches. The check itself will not move a round, so founders should treat the engagement as advisory-first, with the small check serving as a signal of conviction and the value concentrated in advisory and network access. The entry path is a LinkedIn message, ideally warmed by a mutual femtech or DC-area healthcare connection, leading with the user insight, the product wedge, and the specific reason a DC-based angel with her profile is additive to the cap table at pre-seed and seed stage.